Clinical policy: Critical issues in the evaluation and management of adult patients presenting with suspected lower-extremity deep venous thrombosis

Annals of Emergency Medicine

Volumn 42, Issue 1, 2003, Pages 124-135

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE;

CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; EMERGENCY WARD; FIBRINOLYTIC THERAPY; HEALTH CARE POLICY; HUMAN; LEG THROMBOSIS; MEDLINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0038354869     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2003.181     Document Type: Review

References (108)

1. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation. 1996; 93:2212-2245.
2. Davies GS, Salzman EW. The pathogenesis of deep vein thrombosis. In: Joist HJ, Sherman LA, eds. Venous and Arterial Thrombosis: Pathogenesis, Diagnosis, Prevention, and Therapy. New York, NY: Grune & Stratton; 1979:1-22.
3. Bell WR, Simon TL. Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J. 1982;103:239-262.
4. Moser KM, Fedullo PF, LitteJohn JK, et al. Frequent asymptomatic pulmonary embolism in patients with deep venous thrombosis. JAMA. 1994;271:223-225.
5. American College of Emergency Physician. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected pulmonary embolism. Ann Emerg Med. 2003;41:257-270.
6. American College of Emergency Physicians. Clinical policy for the initial approach to adults presenting with a chief complaint of chest pain, with no history of trauma. Ann Emerg Med. 1995;25:274-299.
7. American College of Emergency Physicians. Clinical policy: critical issues in the evaluation and management of adult patients presenting with suspected acute myocardial infarction or unstable angina. Ann Emerg Med. 2000;35:521-544.
8. Monreal M, Lafoz E, Ruiz J, et al. Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest. 1991;99:280-283.
9. Hingorani A, Ascher E, Lorenson E, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg. 1997;26:853-860.
10. American College of Chest Physicians. Consensus Committee on Pulmonary Embolism. Opinions regarding the diagnosis and management of venous thromboembolic disease. Chest. 1998;113:499-504.
11. Hyers TM, Agnelli G, Hull RD, et al. Antithrombotic Therapy for Venous Thromboembolic disease. Chest. 2001;119:176S-193S.
12. Tapson VF, Carroll BA, Davidson BL, et al. The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society. Am J Respir Crit Care Med. 1999;160:1043-1066.
13. Merli G, Spiro TE, Olsson CG, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thrombolic disease. Ann Intern Med. 2001;134:191-202.
14. Hull RD, Raskob GE, Brant RF, et al. Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med. 2000;160:229-236.
15. Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin study Group. N Engl J Med. 1999;341:793-800.
16. Vinson DR, Berman DA. Outpatient treatment of deep venous thrombosis: a clinical care pathway managed by the emergency department. Ann Emerg Med. 2001;37:251-258.
17. PEP Investigators. Prevention of pulmonary embolism and deep vein thrombosis withlow dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-1302.
18. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med. 1998;338:409-415.
19. Douketis JO, Foster GA, Crowther MA, et al. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med. 2000;160:3431-3436.
20. Rutherford SE, Phelan JP. Deep venous thrombosis and pulmonary embolism in pregnancy. Obstet Gynecol Clin North Am. 1991;18:345-370.
21. Erdman WA, Jayson HT, Redman HC, et al. Deep venous thrombosis of extremities: role of MR imaging in the diagnosis. Radiology. 1990;174:425-431.
22. Ghaye B, Szapiro D, Willems V, et al. Combined CT venography of the lower limbs and spiral CT angiography of pulmonary arteries in acute pulmonary embolism: preliminary results of a prospective study. JBR-BTR. 2000;83:271-278.
23. Cham MD, Yankelevitz DF, Shaham D, et al. Deep venous thrombosis: detection by using indirect CT venography. The Pulmonary Angiography-Indirect CT Venography Cooperative Group. Radiology. 2000;216:744-751.
24. Muto P, Lastoria S. Use of radiolabeled peptides to image deep venous thrombosis and pulmonary embolism. J Nucl Med. 2000;41:1065-1066.
25. Butler SP, Rahman T, Boyd SJ, et al. Detection of postoperative deep-venous thrombosis using technetium-99m-labeled tissue plasminogen activator. J Nucl Med. 1997;38:219-223.
26. Klem JA, Schaffer JV, Crane PD, et al. Detection of deep venous thrombosis by DMP 444, a platelet IIb/IIIa antagonist: a preliminary/report. J Nucl Cardiol. 2000;7:359-364.
27. Hull RD, Raskob GE, Ginsberg JS, et al. A noninvasive strategy for the treatment of patients with suspected pulmonary embolism. Arch Intern Med. 1994;154:289-297.
28. Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Prospective Investigation of Pulmonary Embolism Diagnosis. Arch Intern Med. 1995;155:2101-2104.
29. Ginsberg JS, Wells PS, Hirsh J, et al. Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. Arch Intern Med. 1994; 154:1930-1933.
30. Kearon C, Julian JA, Newman TE, et al. Noninvasive diagnosis of deep venous thrombosis. Ann Intern Med. 1998;128:663-677.
31. Turner IC, McNally MA, O'Connell BM, et al. Numerical model of deep venous thrombosis detection using venous occlusion strain gauge plethysmography. Med Biol Eng Comput. 2000;38:348-355.
32. Warwick DJ, Thornton MJ, Freeman S, et al. Computerized strain-gauge plethysmography in the diagnosis of symptomatic and asymptomatic venous thrombosis. Br J Radiol. 1994;67:938-940.
33. Maskell NA, Cooke S, Meecham Jones DJ, et al. The use of automated strain gauge plethysmography in the diagnosis of deep vein thrombosis. Br J Radiol. 2002;75:648-651.
34. Kraaijenhagen RA, Lensing AW, Lijmer JG, et al. Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis. Curr Dpin Pulm Med. 1997;3:265-267.
35. Schriger DL, Cantrill SV, Greene CS. The origins, benefits, harms, and implications of emergency medicine clinical policies. Ann Emerg Med. 1993;22:597-602.
36. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
37. Juni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA. 1999;282:1054-1060.
38. Lijmer JG, Mol BW, Heisterkamp S, et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA. 1999;282:1061-1066.
39. Anand SS, Wells PS, Hunt D, et al. Does this patient have deep vein thrombosis? JAMA. 1998;279:1094-1099.
40. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271:703-707.
41. Gallagher EJ. Clinical utility of likelihood ratios. Ann Emerg Med. 1998;31:391-397.
42. Wells PS, Anderson DR, Bormanis J, et al. Value of assessment of pretest probability of deep-vein thrombosis in clinical management. Lancet. 1997;350:1795-1798.
43. Bigaroni A, Perrier A, Bounameaux H. Is clinical probability assessment of deep vein thrombosis by a score really standardized? Thromb Haemost. 2000;83:788-789.
44. Wells PS, Anderson DR. Diagnosis of deep-vein thrombosis in the year 2000. Curr Opin Pulm Med. 2000;6:309-313.
45. D'Angelo A, D'Alessandro G, Tomassini L, et al. Evaluation of a new rapid quantitative D-dimer assay in patients with clinically suspected deep vein thrombosis. Thromb Haemost. 1996;75:412-416.
46. Dale S, Gogstadd GO, Brosstad F, et al. Comparison of three D-dimer assays for the diagnosis of DVT: ELISA, latex and an immunofiltration assay (NycoCard D-dimer). Thromb Haemost. 1994;71:270-274.
47. Janssen MC, Heebels AE, de Metz M, et al. Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep venous thrombosis. Thromb Haemost. 1997;77:262-266.
48. Perrier A, Desmarais S, Miron MJ, et al. Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;353:190-195.
49. Knecht MF, Heinrich F. Clinical evaluation of an immunoturbidimetric D-dimer assay in the diagnostic procedure of deep vein thrombosis and pulmonary embolism. Thromb Res. 1997;88:413-417.
50. Leroyer C, Escoffre M, LeMoigne E, et al. Diagnostic value of a new sensitive membrane based technique for instantaneous D-dimer evaluation in patients with clinically suspected deep venous thrombosis. Thromb Haemost. 1997;77:637-640.
51. Johna S, Cemaj S, O'Callaghan T, Catalano R. Effect of tissue injury on D-dimer levels: a prospective study in trauma patients. Med Sci Monit. 2002; 8:CR5-8 [III].
52. Owings JT, Gosselin RC, Anderson JT, et al. Practical utility of the D-dimer assay for excluding thromboembolism in severely injured trauma patients. J Trauma. 2001;51:425-429.
53. Brown MD, Rowe BH, Reeves MJ, et al. The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism. Ann Emerg Med. 2002;40:133-144.
54. Schutghens RJ, Esseboom EU, Haas FJ, et al. Usefulness of a semiquantitative D-dimer test for the exclusion of deep venous thrombosis in outpatients. Am J Med. 2002;112:617-621.
55. Oger E, Leroyer C, Bressollette L, et al. Evaluation of a new, rapid, and quantitative D-dimer test in patients with suspected pulmonary embolism. Am J Respir Crit Care Med. 1998;158:65-70.
56. Veitl M, Hamwi A, Kurtaran A, et al, Comparison of four rapid D-dimer tests for diagnosis of pulmonary embolism. Thromb Res. 1996;82:399-407.
57. Duet M, Benelhadj S, Kedra W, et al. A new quantitative D-dimer assay appropriate in emergency: reliability of the assay for pulmonary embolism exclusion diagnosis. Thromb Res. 1998;91:1-5.
58. Gosselin RC, Dwings JT, Utter GH, et al. A new method for measuring D-dimer using immunoturbidometry: a study of 255 patients with suspected pulmonary embolism and deep vein thrombosis. Blood Coagul Fibrinolysis. 2000;11:715-721.
59. Legnani C, Pancani C, Palareti G, et al. Contribution of a new, rapid, quantitative and automated method for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients. Blood Coagul Fibrinolysis. 1999;10:69-74.
60. Keeling DM, Wright M, Baker P, et al. D-Dimer for the exclusion of venous thromboembolism: comparison of a new automated latex particle immunoassay (MDA D-dimer) with an established enzyme-linked fluorescent assay (VIDAS D-dimer). Clin Lab Haematol. 1999;21:359-362.
61. Freyburger G, Trillaud H, Labrouche S, et al. D-dimer strategy in thrombosis exclusion - a gold standard study in 100 patients suspected of deep venous thrombosis or pulmonary embolism: 8 DD methods compared. Thromb Haemost. 1998;79:32-37.
62. Hansson PO, Eriksson H, Eriksson E, et al. Can laboratory testing improve screening strategies for deep vein thrombosis at an emergency unit? J Intern Med. 1994;235:143-151.
63. Kozman H, Flemmer MC, Rahnama M. Deep venous thrombosis: prediction by D-dimer? South Med J 1997;90:907-910.
64. Bongard O, Wicky J, Peter R, et al. D-Dimer plasma measurement in patients undergoing major hip surgery: use in the prediction and diagnosis of postoperative proximal vein thrombosis. Thromb Res. 1994;74:487-493.
65. Bounameaux H, Schneider PA, Reber G, et al. Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. Am J Clin Pathol. 1989;91:82-85.
66. de Moerloose P, Desmarais S, Bounameaux H, et al. Contribution of a new, rapid, individual and quantitative automated D-dimer ELISA to exclude pulmonary embolism. Thromb Haemost. 1996;75:11-13.
67. Mauron T, Baumgartner I, Z'Brun A, et al. SimpliRED D-dimer assay: comparability of capillary and citrated venous whole blood, between-assay variability, and performance of the test for exclusion of deep venous thrombosis in symptomatic outpatients. Thromb Haemost. 1998;79:1217-1219.
68. Wells PS, Anderson DR, Bormanis J, et al. SimpliRED D-dimer can reduce the diagnostic tests in suspected deep vein thrombosis. Lancet. 1998;351:1405-1406.
69. Wildberger JE, Vorwerk D, Kilbinger M, et al. Bedside testing (SimpliRED) in the diagnosis of deep vein thrombosis. Evaluation of 250 patients. Invest Radiol. 1998;33:232-235.
70. Wells PS, Brill-Edwards P, Stevens P, et al. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation. 1995;91:2184-2187.
71. Dryjski M, O'Brien-Irr MS, Harris LM, et al. Evaluation of a screening protocol to exclude the diagnos s of deep venous thrombosis among emergency department patients. J Vasc Surg. 2001;34:1010-1015.
72. Lennox AF, Konstantinos TD, Serunkuma S et al. Combination of a clinical risk assessment score and rapid whole blood D-dimer testing in the diagnosis of deep vein thrombosis in symptomatic patients. J Vasc Surg. 1999;30:794-804.
73. Cornuz J, Ghali WA, Hayoz D, et al. Clinical prediction of deep venous thrombosis using two risk assessment methods in combination with rapid quantitative D-dimer testing. Am J Med. 2002;112:198-203.
74. Anderson OR, Wells PS, Stiell I, et al. Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing. J Emerg Med. 2000;19:225-230.
75. Kraaiienhagen RA, Piovella F, Bemardi E, et al. Simplification of the diagnostic management of suspected deep vein thrombosis. Arch Intern Med. 2002;162:907-911.
76. Farrell S, Hayes T, Shaw M. A negative SimpliRED D-dimer assay result does not exclude the diagnosis of deep vein thrombosis or pulmonary embolus in emergency department patients. Ann Emerg Med. 2000;35:121-125.
77. Kline JA, Johns KL, Colucciello SA, et al. New diagnostic tests for pulmonary embolism. Ann Emerg Med. 2000;35:168-180.
78. Reber G, Bounameaux H, Perrier A, et al. Evaluation of advanced D-dimer assay for the exclusion of venous thromboembolism. Thromb Res. 2002;107:197-200.
79. Kearon C, Julian JA, Newman TE, et al. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann Intern Med. 1998;128:663-677.
80. Lensing AW, Prandoni P, Brandjes D, et al. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med. 1989;320:342-345.
81. Killewich LA, Bedford GR, Beach KW, et al. Diagnosis of deep venous thrombosis. A prospective study comparing duplex scanning to contrast venography. Circulation. 1989;79:810-814.
82. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med. 1998;129:1044-1049. Review.
83. Daniel KR, Jackson RE, Kline JA. Utility of lower extremity venous ultrasound in the diagnosis and exclusion of pulmonary embolism in outpatients. Ann Emerg Med. 2000;35:547-554.
84. Gottlieb RH, Widjaja J, Mehra S, et al. Clinically important pulmonary emboli: does calf vein US alter outcomes? Radiology. 1999;211:25-29.
85. Masuda EM, Kessler DM, Kistner RL, et al. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux. J Vasc Surg. 1998;28:67-73.
86. Meissner MH, Caps MT, Bergelin RD, et al. Early outcome after isolated calf vein thrombosis. J Vasc Surg. 1997;26:749-756.
87. McLafferty RB, Moneta GL, Passman MA, et al. Late clinical and hemodynamic sequelae of isolated calf vein thrombosis. J Vasc Surg. 1998;27:50-56.
88. Passman MA, Moneta GL, Taylor LM Jr, et al. Pulmonary embolism is associated with the combination of isolated calf vein thrombosis and respiratory symptoms. J Vasc Surg. 1997;25:39-45.
89. Lagerstedt CI, Dlsson CG, Fagher BD, et al. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet. 1985;2:515-518.
90. Kazmers A, Groehn H, Meeker C. Acute calf vein thrombosis. Am Surg. 1999;65:1124-1127.
91. Ohgi S, Tachibana M, Ikebuchi M, et al. Pulmonary embolism in patients with isolate soleal vein thrombosis. Angiology. 1998;49:759-764.
92. Schwarz T, Schmidt B, Beyer J, et al. Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin. Blood Coag Fibrinolysis. 2001;12:597-599.
93. Astermark J, Bjorgell O, Linden E, et al. Low recurrence rate after deep calf-vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med. 1998;244:79-82.
94. Pinede L, Ninet J, Duhaut P, et al. Comparison of 3 and 6 months of oral anti-coagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001;103:2453-2460.
95. Pinede L, Cucherat M, Duhaut P, et al. Optimal duration of anticoagulant therapy after an episode of venous thromboembolism. Blood Coagul Fibrinolysis. 2000;11:701-708.
96. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998;129:997-1005.
97. Heijboer H, Buller HR, Lensing A, et al. A comparison of real-time compression ultrasonography with impedance plethysmography for the diagnosis of deep-vein thrombosis in symptomatic outpatients. N Engl J Med. 1993;329:1365-1369.
98. Birdwell BG, Raskob GE, Whitsett TL, et al. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998;128:1-7.
99. Kanter DS, Mikkola KM, Patel SR, et al. Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997;111:1241-1245.
100. O'Meara JJ, McNutt RA, Evans AT, et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med. 1994;330:1864-1869.
101. Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36:1336-1343.
102. Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000;32:130-137.
103. Goldhaber SZ, Buring JE, Lipnick RJ, et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984;76:393-397.
104. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal vein thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838-843.
105. Ouriel K, Katzen B, Mewissen M, et al. Reteplase in the treatment of peripheral arterial and venous occlusions: a pilot study. J Vasc Interv Radiol. 2000;11:849-854.
106. Schweizer J, Elix H, Altmann E, et al. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study. Vasa. 1998;27:167-171.
107. Martin M, Heimig T, Fiebach BJ, et al. Fibrinolytic treatment with ultra-high streptokinase infusion via the dorsalis pedis vein offers no advantage over systemic infusion via the brachial vein in patients with deep vein thrombosis of the leg. Vasa. 1996;25:275-278.
108. Manco-Johnson MJ, Nuss R, Hays T, et al. Combined thrombolytic and anti-coagulant therapy for venous thrombosis in children. J Pediatr. 2000;136:446-453.